Xcout Intel
AGC Biologics competitors & alternatives
The 12 closest competitors and alternatives to AGC Biologics among biotech companies — ranked by similarity to what AGC Biologics actually does, not by market-cap band.
Subscribe to see AGC Biologics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AGC Biologics
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
AGC Biologics at a glance
AGC Biologics is a biotech company headquartered in United States. Xcout tracks 10 named people at AGC Biologics, including Alberto Santagostino (Chief Executive Officer and President). Xcout recorded 1 job posting from AGC Biologics in the last 90 days.
AGC Biologics leadership
- Alberto SantagostinoChief Executive Officer and President
- Christoph WinterhalterChief Business Officer
- Kasper MøllerExecutive Vice President and General Manager, Copenhagen Facility
- Luca AlbericiExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility
- Yuichiro “Roy” TashiroExecutive Vice President, Corporate Functions
- Dieter KramerSenior Vice President and General Manager, Heidelberg Facility
4 more named people on record for AGC Biologics, with roles, board committees and tenure — see the full roster →
Hiring at AGC Biologics
Xcout recorded 1 job posting from AGC Biologics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see AGC Biologics's hiring signals →
Recent AGC Biologics news
Top 12 AGC Biologics competitors
Ranked by semantic similarity — how close each company is to AGC Biologics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Similar biotech company
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Similar biotech company
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Biotechnology
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Similar biotech company
Mabion SA operates as a biotechnology company and Contract Development and Manufacturing Organization (CDMO) that provides services encompassing process development, analytics, and drug substance manufacturing. The company specializes in working with biologics such as biosimilars, antibodies, antibody-drug conjugates (ADCs), and recombinant therapeutic proteins to serve biopharmaceutical clients.
Similar biotech company
Alvotech specializes in the development and manufacturing of biosimilars to expand access to affordable biologic medicines for patients worldwide. The company utilizes a vertically integrated approach spanning from cell line development to fill and finish manufacturing.
Similar biotech company
Evotec is a life science company that provides drug discovery and preclinical development services, working across modalities from small molecules to biotherapeutics. Through its subsidiary Just - Evotec Biologics, the company focuses on the design, development, and manufacturing of biologics to make therapies more accessible and affordable for partners in the pharmaceutical and biotechnology industries.
Biotechnology
JHL Biotech, Inc. is a biopharmaceutical company headquartered in Zhubei, Taiwan, with established research, development, and manufacturing facilities. The company focuses on supporting pre-clinical and early clinical biologic developments.
Similar biotech company
Rentschler Biopharma SE is a contract development and manufacturing organization (CDMO). It is part of Dr. Rentschler Holding GmbH & Co. KG and its employees make up the majority of the 1300 workers employed by the parent organization.
Similar biotech company
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Similar biotech company
Established in 1995 and headquartered in Tokyo, Japan, MEDINET Co., Ltd. functions as a contract development and manufacturing organization (CDMO) primarily focused on regenerative medicine and cell therapy solutions within Japan. The company furnishes comprehensive support for immuno-cell therapy, encompassing critical elements such as specialized technical expertise, advanced facilities, robust operational systems, essential materials, and skilled cell engineers. Furthermore, MEDINET actively manufactures regenerative medical products, investigational cell products, and other specified cell-based therapies. Its extensive value chain offerings also cover personnel training, facility and equipment design, operational management, standard operating procedure (SOP) preparation, logistics networks, information systems, purchasing and production management, stringent quality management and assurance, and technology transfer and process development. The firm actively collaborates with and supports medical institutions, research organizations, and biopharmaceutical companies in their endeavors to advance immuno-cell therapy.
Similar biotech company
Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise structures its operations into four key divisions: The Life Science Services and Products segment delivers a wide array of research offerings, such as gene and oligonucleotide synthesis, molecular cloning, protein and peptide engineering, antibody production, molecular diagnostic instruments, and genomic editing materials. These resources are instrumental for fundamental biological investigations, pharmaceutical and drug discovery, disease diagnostics, vaccine development, and applications in agriculture, environmental science, and food production. The Biologics Development Services division supports pharmaceutical, biotechnology, governmental, and academic institutions. It provides comprehensive services for the full lifecycle of therapeutic antibodies, from initial discovery through pre-clinical and clinical development, alongside pre-clinical and clinical development for plasmids and viruses, and broader gene and cell therapy development. Dedicated to industrial applications, the Industrial Synthetic Biology Products segment engineers non-pathogenic microbial strains and manufactures specialized enzymes. These enzymes find utility across the food processing, animal feed, pharmaceutical, and chemical sectors. Finally, the Cell Therapy unit focuses on the pioneering discovery and advanced development of chimeric antigen receptor T-cell (CAR-T) therapies, specifically designed to combat both liquid and solid malignant tumors.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AGC Biologics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AGC Biologicsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →